$144.94
+2.29 (+1.61%)
Last updated: May 30, 2026 23:25
Fundamentals Overview
Insulet Corporation is near the low of its 52-week range with premium valuation, trading relatively flat today.
Valuation premium
Profitability
Risk (Beta)
1.2 — in line vol
Earnings & growth
BullzEye Analysis
Our composite tilts Hold on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.
Composite Signal
Supporting (Buy):
Analyst grade: B
Pressures (Sell):
Sentiment weakening (2 downgrades) · 3M vs S&P 500: -51% · 3M vs Healthcare sector: -35.6%
Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.
Key Stats
About
Ratings & Grades at a Glance
Overall rating: B. Recent institutional grades: majority downgrades. Current institutional positions: Buy: 14, Neutral: 3, Outperform: 9, Overweight: 3, Underweight: 1.
Valuation & Ratios
Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.
DCF vs price: DCF estimate is $-32.39; current price is $144.94. That’s a -122.4% gap. When the gap is large (e.g. >20%), that’s divergence; when they’re close, that’s convergence. Differences can reflect growth expectations, sector premiums, or conservative vs. optimistic assumptions. Use DCF as one input alongside technicals and sentiment.
| Metric | Value |
|---|---|
| Valuation | |
| P/E (TTM) | 33.6 |
| PEG (TTM) | N/A |
| P/B (TTM) | 7.79 |
| P/S (TTM) | 3.46 |
| P/FCF (TTM) | 24.36 |
| Liquidity & enterprise | |
| Current Ratio (TTM) | 2.49 |
| Quick Ratio (TTM) | 1.81 |
| Cash Ratio (TTM) | 0.7 |
| Profitability | |
| ROE (TTM) | N/A |
| ROA (TTM) | N/A |
| Revenue growth (YoY) | N/A |
| Net margin (TTM) | 10.44% |
| Gross margin (TTM) | 71.01% |
| Operating margin (TTM) | 17.48% |
| Debt to equity (TTM) | N/A |
Latest News
News loads when you open this tab.
Price Target, Ratings & Grades
Analyst price targets, consensus, rating snapshot, and institutional grades for PODD.
Analyst Sentiment at a Glance
Stock Grades (Institutions)
| Institution | Action | Previous Grade | New Grade | Date |
|---|---|---|---|---|
| Citigroup | maintain | Neutral | Neutral | 2026-05-28 |
| RBC Capital | maintain | Outperform | Outperform | 2026-05-27 |
| BTIG | maintain | Buy | Buy | 2026-05-27 |
| B of A Securities | maintain | Buy | Buy | 2026-05-18 |
| Barclays | maintain | Underweight | Underweight | 2026-05-08 |
| JP Morgan | maintain | Overweight | Overweight | 2026-05-07 |
| Wells Fargo | maintain | Overweight | Overweight | 2026-05-07 |
| Truist Securities | maintain | Buy | Buy | 2026-05-07 |
| Bernstein | maintain | Outperform | Outperform | 2026-05-07 |
| RBC Capital | maintain | Outperform | Outperform | 2026-05-07 |
| Canaccord Genuity | maintain | Buy | Buy | 2026-05-07 |
| Oppenheimer | maintain | Outperform | Outperform | 2026-05-07 |
| Evercore ISI Group | maintain | Outperform | Outperform | 2026-05-07 |
| BTIG | maintain | Buy | Buy | 2026-05-06 |
| Rothschild & Co | downgrade | Buy | Neutral | 2026-04-24 |
| Truist Securities | maintain | Buy | Buy | 2026-04-15 |
| Goldman Sachs | maintain | Buy | Buy | 2026-04-09 |
| Citigroup | downgrade | Buy | Neutral | 2026-04-07 |
| Citigroup | maintain | Buy | Buy | 2026-03-11 |
| Evercore ISI Group | maintain | Outperform | Outperform | 2026-02-19 |
| Bernstein | maintain | Outperform | Outperform | 2026-02-19 |
| Leerink Partners | maintain | Outperform | Outperform | 2026-02-19 |
| Truist Securities | maintain | Buy | Buy | 2026-02-19 |
| Canaccord Genuity | maintain | Buy | Buy | 2026-02-19 |
| JP Morgan | maintain | Overweight | Overweight | 2026-02-19 |
| Oppenheimer | maintain | Outperform | Outperform | 2026-02-19 |
| Goldman Sachs | maintain | Buy | Buy | 2026-02-19 |
| Citigroup | maintain | Buy | Buy | 2026-02-19 |
| BTIG | maintain | Buy | Buy | 2026-02-18 |
| Stifel | maintain | Buy | Buy | 2026-02-04 |